terlipressin has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dębowski, D; Gitlin-Domagalska, A; Glavaš, M; Ptaszyńska, N; Rolka, K; Łęgowska, A | 1 |
| Chen, L; Li, H; Ma, K; Zhang, Q | 1 |
1 review(s) available for terlipressin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Vasopressin and Its Analogues: From Natural Hormones to Multitasking Peptides.
Topics: Animals; Antidiuretic Agents; COVID-19; COVID-19 Drug Treatment; Deamino Arginine Vasopressin; Diabetes Insipidus; Hemostatics; Humans; Lypressin; Molecular Structure; Ornipressin; Pandemics; SARS-CoV-2; Terlipressin; Vasopressins | 2022 |
1 other study(ies) available for terlipressin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Clinical considerations for a gastric Dieulafoy's disease patient: Cardiac arrhythmias caused by SARS-CoV-2 or terlipressin?
Topics: Arrhythmias, Cardiac; COVID-19; Gastrointestinal Hemorrhage; Humans; SARS-CoV-2; Terlipressin | 2023 |